Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

13 articles matching "support"

ResearchPUBMED6 days ago

'If You Don't Fight for Yourself, No One Else Will': An In-Depth Interpretative Phenomenological Analysis of Rare Disorder Care Advocacy in Aotearoa New Zealand.

Researchers in New Zealand interviewed 15 people with rare diseases and their caregivers to understand what it's like to get diagnosed and treated. They found that patients often have to fight hard to get answers and support because doctors don't know much about rare diseases. The study shows that people with rare diseases face similar challenges, even though their specific conditions are very different.

WHY IT MATTERSThis research directly documents the real-world barriers that rare disease patients face in accessing diagnosis and care in New Zealand, providing evidence that could help healthcare systems improve support for the estimated 300 million people worldwide living with rare disorders.
Good to knowRead →
ResearchPUBMEDApr 17

Predictors of quality of life in parents of children with rare diseases: a tertiary care center cross-sectional study in Saudi Arabia.

Researchers in Saudi Arabia studied how different factors affect the stress and well-being of parents who have children with three rare genetic diseases: cystic fibrosis, congenital adrenal hyperplasia, and Duchenne muscular dystrophy. They surveyed 107 parents and found that things like whether parents work, family income, and cultural factors all play a role in how well parents cope with having a sick child. Understanding these factors can help doctors and support services better help families dealing with rare diseases.

WHY IT MATTERSIf you're a parent of a child with CF, CAH, or DMD, this research identifies specific factors affecting your quality of life—such as employment status and family support—that healthcare providers can now address to improve your family's well-being.
Good to knowCystic FibrosisCongenital Adrenal HyperplasiaDuchenne Muscular DystrophyRead →
ResearchCLINICALTRIALSApr 14

Trial Completed: Using Social Robots in Children With Rare Diseases and Their Parents: A Feasibility Study (NCT06466109)

Researchers completed a small study with 14 children who have rare diseases and their parents to test whether a social robot could help families cope better. The robot was designed to provide support and improve relationships between parents and children while reducing stress and worry. The study looked at whether families found the robot helpful and acceptable to use in their daily lives.

WHY IT MATTERSThis completed trial demonstrates a novel approach to family-centered support for rare disease patients—social robots may offer accessible emotional and relational support when specialized mental health resources for rare disease families are limited.
Good to knowRead →
ResearchPUBMEDApr 10

Coping with the challenges of caregiving: A qualitative exploration of the experiences of family caregivers of children with rare diseases in South Africa.

This study talked to 10 parents in South Africa whose children have rare diseases to understand what challenges they face as caregivers. The parents said they struggle with stress, worry about their children's health, and sometimes feel tired and sad. The researchers want doctors and hospitals to better understand what caregivers go through so they can offer more help and support.

WHY IT MATTERSIf you're caring for a child with a rare disease, this research validates that your struggles are real and documented — and shows healthcare systems need to provide better caregiver support services.
Good to knowRead →
ResearchPUBMEDApr 3

Systematic benchmarking demonstrates large language models have not reached the diagnostic accuracy of traditional rare-disease decision support tools.

Researchers tested whether artificial intelligence chatbots like ChatGPT could diagnose rare genetic diseases by comparing them to a traditional diagnostic tool called Exomiser. They tested seven different AI models on over 5,000 real patient cases. The study found that even the best AI chatbots were not as accurate as the existing diagnostic tool at identifying the correct disease.

WHY IT MATTERSIf you're waiting for a diagnosis for a rare genetic disease, this research shows that AI chatbots alone shouldn't replace traditional diagnostic tools—your doctor should continue using proven methods alongside any new technology.
Good to knowRead →
ResearchPUBMEDApr 1

The Validity and Reliability of the Turkish Version of the Parental Needs Scale for Rare Diseases (PNS-RD).

Researchers in Turkey tested a new questionnaire called the Parental Needs Scale for Rare Diseases to measure what parents of children with rare diseases need most. The study included 264 parents and used statistical tests to make sure the questionnaire works well and gives consistent results. This tool can help doctors and support programs better understand and meet the needs of families dealing with rare diseases.

WHY IT MATTERSThis validated assessment tool enables healthcare systems to systematically identify and address the specific economic, emotional, and physical support needs of parents caring for children with rare diseases, potentially improving family quality of life and care outcomes.
Good to knowrare diseases (general)Read →
ResearchCLINICALTRIALSMar 30

Trial Completed: Rare Group Problem Management Plus (NCT06548022)

Researchers at Children's National completed a study testing a new support program for parents of children with rare diseases. The program, called Rare Group Problem Management Plus, brought parents together once a week for 5 weeks to help them manage stress, anxiety, and emotional challenges. The small study included 8 parents and focused on teaching practical coping skills in a group setting where everyone had similar experiences.

WHY IT MATTERSThis completed trial demonstrates that group-based support programs specifically designed for parents of children with rare conditions can address the significant mental health burden these families face, potentially offering a scalable model for other rare disease communities.
Good to knowrare genetic conditions (unspecified)anxiety disordersdepressionRead →
ResearchCLINICALTRIALSMar 30

Trial Now Recruiting: Caregiving Networks Across Disease Context and the Life Course (NCT05007990)

This study is looking for 2,800 people to help researchers understand how being a caregiver affects a person's health and stress levels over time. The study includes caregivers of people with rare diseases like Batten disease, Tay-Sachs disease, and other inherited metabolic disorders, as well as caregivers of people with undiagnosed diseases. By learning more about caregiver stress, researchers hope to find ways to better support the millions of unpaid family caregivers in the U.S.

WHY IT MATTERSIf you or a family member care for someone with a rare inherited metabolic disorder, Batten disease, Tay-Sachs, or an undiagnosed disease, this study directly addresses the health challenges caregivers face and could lead to better support resources.
You can act on thisBatten diseaseTay-Sachs diseaseInherited metabolic disordersRead →
ResearchPUBMEDMar 26

TikTok as a Platform for Patient Education and Health Information in Rare Genetic Diseases: Cross-Sectional Study.

Researchers studied 184 videos on TikTok about five rare genetic diseases to see how well the platform helps patients learn about their conditions and connect with others. They found that TikTok is being used by patients to share information and build community, but the study looked at whether this information was accurate and helpful. This research shows that social media is becoming an important place where people with rare diseases find support and learn about their conditions.

WHY IT MATTERSIf you have Ehlers-Danlos syndrome, Marfan syndrome, cystic fibrosis, Wilson disease, or Gaucher disease, this study reveals what kind of health information is actually available on TikTok and whether you can trust it for learning about your condition.
Good to knowEhlers-Danlos syndromeMarfan syndromeCystic fibrosisRead →
ResearchPUBMEDMar 26

Rare Pediatric Pulmonary Diseases: Insights from a Survey of Pediatric Pulmonologists in German-Speaking Countries.

Doctors who treat children with rare lung diseases in German-speaking countries were surveyed about their experience and confidence in diagnosing and treating these conditions. The study found that while common rare lung diseases like cystic fibrosis have good support systems, many other rare lung diseases don't have clear treatment guidelines. Researchers want to understand what training and resources doctors need to better help children with these uncommon lung problems.

WHY IT MATTERSIf you have a child with a rare lung disease, this research could lead to better training for pediatric lung doctors in your region, potentially reducing diagnostic delays and improving access to specialized care.
Good to knowchildhood interstitial lung diseasecongenital thoracic malformationscystic fibrosisRead →
ResearchPUBMEDMar 26

Equity-focused implementation to enhance access to rare disease genomic research and understand diverse perspectives.

Researchers tested new ways to help more diverse groups of people join rare disease genetic studies. They used strategies like having doctors refer patients, providing language support, and bringing blood tests to people's homes. About 83% of people they tried to recruit successfully joined the study, showing these methods work well.

WHY IT MATTERSIf you or your family member has a rare disease and belongs to a group that has been underrepresented in genetic research, this work means future studies are more likely to actively recruit and support your participation, potentially leading to better understanding of your condition.
Good to knowrare diseases (general)Read →
ResearchCLINICALTRIALSMar 26

Trial Completed: Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and Dermatologists (NCT07428915)

Researchers completed a study testing whether an AI tool called Legit.Health Plus can help doctors better diagnose rare and complicated skin conditions. The tool was tested with 15 healthcare providers to see if it could reduce the gap between what general doctors and skin specialists diagnose. This matters because conditions like Generalized Pustular Psoriasis and Hidradenitis Suppurativa can be missed or misdiagnosed, delaying proper treatment.

WHY IT MATTERSThis completed trial tested an AI diagnostic tool specifically designed to help primary care doctors accurately identify rare skin conditions like Generalized Pustular Psoriasis and Hidradenitis Suppurativa, which are often missed in non-specialist settings.
Good to knowGeneralized Pustular PsoriasisPustular PsoriasisHidradenitis SuppurativaRead →
ResearchCLINICALTRIALSMar 26

Trial Now Recruiting: Human Biospecimen Procurement Protocol: Biorepository to Support Translational Research to Identify Disease Mechanism(s) (NCT02543996)

Researchers at the National Heart, Lung, and Blood Institute are collecting blood and tissue samples from up to 10,000 people to study rare genetic diseases. They want to understand what causes these diseases by examining the samples in a lab. People of any age with undiagnosed or heart and lung diseases can participate. Samples can be collected at the NIH Clinical Center or through your own doctor.

WHY IT MATTERSThis biorepository is actively recruiting and could help researchers identify the genetic causes of your undiagnosed condition, potentially leading to better treatments and diagnosis methods for rare diseases.
You can act on thisUndiagnosed DiseasesRare Genetic DiseasesCardiovascular DiseaseRead →

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases